217 related articles for article (PubMed ID: 24240680)
1. Transformation by Hras(G12V) is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition.
Chen X; Makarewicz JM; Knauf JA; Johnson LK; Fagin JA
Oncogene; 2014 Nov; 33(47):5442-9. PubMed ID: 24240680
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
3. A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse.
Trempus CS; Bishop WR; Njoroge FG; Doll RJ; Battalora MS; Mahler JF; Haseman JK; Tennant RW
Mol Carcinog; 2000 Jan; 27(1):24-33. PubMed ID: 10642434
[TBL] [Abstract][Full Text] [Related]
4. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
5. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
To MD; Rosario RD; Westcott PM; Banta KL; Balmain A
Oncogene; 2013 Aug; 32(34):4028-33. PubMed ID: 22945650
[TBL] [Abstract][Full Text] [Related]
6. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
7. Alterations in protein kinase C isozymes alpha and beta 2 in activated Ha-ras containing papillomas in the absence of an increase in diacylglycerol.
Mills KJ; Bocckino SB; Burns DJ; Loomis CR; Smart RC
Carcinogenesis; 1992 Jul; 13(7):1113-20. PubMed ID: 1638676
[TBL] [Abstract][Full Text] [Related]
8. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analysis of malignant skin tumors induced in chemically treated TG-AC transgenic mice.
French JE; Libbus BL; Hansen L; Spalding J; Tice RR; Mahler J; Tennant RW
Mol Carcinog; 1994 Dec; 11(4):215-26. PubMed ID: 7999263
[TBL] [Abstract][Full Text] [Related]
10. Characterization of benzo[a]pyrene-initiated mouse skin papillomas for Ha-ras mutations and protein kinase C levels.
Colapietro AM; Goodell AL; Smart RC
Carcinogenesis; 1993 Nov; 14(11):2289-95. PubMed ID: 8242857
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
[TBL] [Abstract][Full Text] [Related]
12. v-Ha-ras-induced mouse skin papillomas exhibit aberrant expression of keratin K13 as do their 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate -induced analogues.
Sutter C; Strickland JE; Welty DJ; Yuspa SH; Winter H; Schweizer J
Mol Carcinog; 1991; 4(6):467-76. PubMed ID: 1724371
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice.
Chandramouli A; Shi J; Feng Y; Holubec H; Shanas RM; Bhattacharyya AK; Zheng W; Nelson MA
Carcinogenesis; 2007 Sep; 28(9):2028-35. PubMed ID: 17389615
[TBL] [Abstract][Full Text] [Related]
15. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
16. Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development.
Formisano P; Perruolo G; Libertini S; Santopietro S; Troncone G; Raciti GA; Oriente F; Portella G; Miele C; Beguinot F
Oncogene; 2005 Oct; 24(47):7012-21. PubMed ID: 16044159
[TBL] [Abstract][Full Text] [Related]
17. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
[TBL] [Abstract][Full Text] [Related]
18. Dual-specificity phosphatase 5 regulates nuclear ERK activity and suppresses skin cancer by inhibiting mutant Harvey-Ras (HRasQ61L)-driven SerpinB2 expression.
Rushworth LK; Kidger AM; Delavaine L; Stewart G; van Schelven S; Davidson J; Bryant CJ; Caddye E; East P; Caunt CJ; Keyse SM
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18267-72. PubMed ID: 25489104
[TBL] [Abstract][Full Text] [Related]
19. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
20. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
